Aubrey Rankin - 15 Aug 2021 Form 4 Insider Report for Revance Therapeutics, Inc.

Signature
/s/ Dwight Moxie, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Aug 2021
Net transactions value
-$375,432
Form type
4
Filing time
17 Aug 2021, 18:20:10 UTC
Previous filing
30 Jul 2021
Next filing
06 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Tax liability $128,773 -4,949 -6.2% $26.02 74,827 15 Aug 2021 Direct F1, F2
transaction RVNC Common Stock Sale $246,659 -9,364 -13% $26.34 65,463 16 Aug 2021 Direct F3, F4
holding RVNC Common Stock 321,611 15 Aug 2021 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009 F5
holding RVNC Common Stock 154,302 15 Aug 2021 The Rankin Irrevocable Trust F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on August 15, 2021, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 57,251 shares. The RSA vests in three equal annual installments from August 15, 2020, subject to Mr. Rankin's Continuous Service (as defined in the Issuer's 2014 Inducement Plan (the "Plan")) on each vesting date.
F2 The fair market value was determined on August 13, 2021 pursuant to the Plan.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
F4 The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $26.71. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
F6 These shares are held by The Rankin Irrevocable Trust, of which the children of Mr. Rankin are beneficiaries.